Meeting your needs with CMet
MabXience launches a powerful c-Met immunohistochemistry antibody, striving to support precise diagnosis and treatment and maximize benefits for patients with c-Met overexpressing tumors!
Companion Diagnostic “Diamond” Target – NTRK
Our self-developed antibody pan-TRK (MXRO32) reacts with the conserved proprietary peptide sequence at the C-terminus of TRKA, TRKB, and TRKC, covering all fusion types and significantly improving the detection rate of NTRK fusion genes, making it the most cost-effective initial screening tool in clinical practice.
Welcome to the world of Maixin Immunohistochemistry!
Fuzhou Maixin Biotechnology Development Co., Ltd., established in 1993, is a high-tech biomedical enterprise founded by overseas-educated experts and scholars, specializing in the research, development, and production of immunohistochemical pathology products.
MaiXin News
Lumatas fully automated pathology staining system
The Lumatas fully automated staining system is used in staining experiments such as immunohistochemistry and in situ hybridization. It allows for the processing of a larger number of immunohistochemistry specimens without increasing personnel, shortening testing time while achieving high-quality staining results. The fully automated platform effectively avoids human error and closely simulates manual immunohistochemistry staining procedures, allowing reagents used in manual procedures to be easily adapted to automated operation, ensuring stable and reliable experimental results and laying the foundation for the standardization of immunohistochemistry.
learn more
Maixin’s Proprietary Monoclonal Antibodies
For a long time, the production technology and processes of murine monoclonal antibodies have been mainly controlled by a few developed countries in Europe and America. In my country, only a few biotechnology companies could produce rabbit polyclonal antibodies used solely for protein research. Maixin Company organized a research and development team and developed more than twenty types of…
Molecular Pathology Product: RedBright
After years of dedicated research and development, Maixin has finally achieved a breakthrough in FISH probe preparation technology. Extensive experimental verification and comparison have confirmed that our newly developed FISH probes meet or even exceed the international advanced standards for similar probes in all performance indicators.
Maixin Pathology Laboratory
Maixin Laboratory was established in the 1990s and has a history of over 20 years. It is one of the earliest laboratories in China to implement immunohistochemistry quality control. It pioneered the concept of immunohistochemistry standardization nationwide, establishing a relatively complete set of quality control methods and procedures. This has made immunohistochemistry technology more standardized, and the results more reliable and reproducible. After more than twenty years of practice and promotion, it has been recognized and praised by peers in the industry. In 2015, the laboratory began to offer FISH testing services externally. Currently, its molecular testing services are provided to numerous hospitals, accumulating extensive experience. The laboratory now possesses advanced scientific research instruments such as a microscopic image analysis system, a fully automatic staining system, and a high-definition image scanner, enabling it to provide customized IHC research services for research institutions and medical units at all levels.